Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
Nature Communications|May 25, 2016
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolutionThomas E Bartlett, Kantaraja Chindera, Jacqueline McDermott, et al.
Clinical Epigenetics|November 24, 2020
DNA methylation signatures to predict the cervicovaginal microbiome statusNuno R Nené, James Barrett, Allison Jones, et al.
Epigenomics|August 12, 2014
DNA methylation markers for early detection of women's cancer: promise and challengesTimo Wittenberger, Sara Sleigh, Daniel Reisel, et al.
Plos Genetics|February 21, 2012
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancerJoanna Zhuang, Allison Jones, Shih-Han Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
Journal of Clinical Epidemiology|November 16, 2010
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking studyNyaladzi Balogun, Aleksandra Gentry-Maharaj, Eva L Wozniak, et al.
Plos One|October 22, 2015
Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived ScentYing Liu, Malcolm C Pike, Nancy Wu, et al.
International Journal of Cancer|September 3, 2022
The WID-qEC test: Performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancersLena Schreiberhuber, Chiara Herzog, Charlotte D Vavourakis, et al.
Studies in Health Technology and Informatics|April 29, 2024
Towards an Electronic Health Prevention Record Based on HL7 FHIR and the OMOP Common Data ModelMarkus Falgenhauer, Aaron Lauschensky, Karl Kreiner, et al.
Clinical Epigenetics|September 17, 2024
Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarraysTatiana Nazarenko, Charlotte Dafni Vavourakis, Allison Jones, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Nature Communications|May 25, 2016
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolutionThomas E Bartlett, Kantaraja Chindera, Jacqueline McDermott, et al.
Clinical Epigenetics|November 24, 2020
DNA methylation signatures to predict the cervicovaginal microbiome statusNuno R Nené, James Barrett, Allison Jones, et al.
Epigenomics|August 12, 2014
DNA methylation markers for early detection of women's cancer: promise and challengesTimo Wittenberger, Sara Sleigh, Daniel Reisel, et al.
Plos Genetics|February 21, 2012
The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancerJoanna Zhuang, Allison Jones, Shih-Han Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
Journal of Clinical Epidemiology|November 16, 2010
Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking studyNyaladzi Balogun, Aleksandra Gentry-Maharaj, Eva L Wozniak, et al.
Plos One|October 22, 2015
Brca1 Mutations Enhance Mouse Reproductive Functions by Increasing Responsiveness to Male-Derived ScentYing Liu, Malcolm C Pike, Nancy Wu, et al.
International Journal of Cancer|September 3, 2022
The WID-qEC test: Performance in a hospital-based cohort and feasibility to detect endometrial and cervical cancersLena Schreiberhuber, Chiara Herzog, Charlotte D Vavourakis, et al.
Studies in Health Technology and Informatics|April 29, 2024
Towards an Electronic Health Prevention Record Based on HL7 FHIR and the OMOP Common Data ModelMarkus Falgenhauer, Aaron Lauschensky, Karl Kreiner, et al.
Clinical Epigenetics|September 17, 2024
Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarraysTatiana Nazarenko, Charlotte Dafni Vavourakis, Allison Jones, et al.
Pageof 18